The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
Abstract
This updated Good Publication Practice (GPP) guideline, known as GPP3, builds on earlier versions and provides recommendations for individuals and organizations that contribute to the publication of research results sponsored or supported by pharmaceutical, medical device, diagnostics, and biotechnology companies. The recommendations are designed to help individuals and organizations maintain ethical and transparent publication practices and comply with legal and regulatory requirements. These recommendations cover publications in peer-reviewed journals and presentations (oral or poster) at scientific congresses. The International Society for Medical Publication Professionals invited more than 3000 professionals worldwide to apply for a position on the steering committee, or as a reviewer, for this guideline. The GPP2 authors reviewed all applications (n = 241) and assembled an 18-member steering committee that represented 7 countries and a diversity of publication professions and institutions. From the 174 selected reviewers, 94 sent comments on the second draft, which steering committee members incorporated after discussion and consensus. The resulting guideline includes new sections (Principles of Good Publication Practice for Company-Sponsored Medical Research, Data Sharing, Studies That Should Be Published, and Plagiarism), expands guidance on the International Committee of Medical Journal Editors' authorship criteria and common authorship issues, improves clarity on appropriate author payment and reimbursement, and expands information on the role of medical writers. By following good publication practices (including GPP3), individuals and organizations will show integrity; accountability; and responsibility for accurate, complete, and transparent reporting in their publications and presentations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
Reducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319
Self-citationAMA manual of style: a guide for authors and editors
(2007) · Choice Reviews Online · doi:10.5860/choice.45-1788 · Cited by 329
Good publication practice for pharmaceutical companies
Wager, E., Field, E. A., & Grossman, L. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001767 · Cited by 148
Self-citationGood publication practice for communicating company sponsored medical research: the GPP2 guidelines
Graf, C., Battisti, W. P., Bridges, D., Bruce-Winkler, V., Conaty, J. M., Ellison, J. M., Field, E. A., Gurr, J. A., Marx, M.-E., Patel, M., et al. (2009) · BMJ · doi:10.1136/bmj.b4330 · Cited by 128
Self-citationWhat Should Be Done To Tackle Ghostwriting in the Medical Literature?
Gøtzsche, P. C., Kassirer, J. P., Woolley, K. L., Wager, E., Jacobs, A., Gertel, A., & Hamilton, C. W. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000023 · Cited by 125
Self-citationJacobs, A., & Wager, E. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x25578 · Cited by 124
Self-citationPublication misconduct and plagiarism retractions: a systematic, retrospective study
Stretton, S., Bramich, N. J., Keys, J. R., Monk, J. A., Ely, J. A., Haley, C., Woolley, M. J., & Woolley, K. L. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.728131 · Cited by 105
Self-citationPlagiarism: Why is it such a big issue for medical writers?
Das, N., & Panjabi, M. (2011) · Perspectives in Clinical Research · doi:10.4103/2229-3485.80370 · Cited by 99
Cited by
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Abou-Alfa, G. K., Lau, G., Kudo, M., Chan, S. L., Kelley, R. K., Furuse, J., Sukeepaisarnjaroen, W., Kang, Y.-K., Van Dao, T., De Toni, E. N., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2100070 · Cited by 1,576
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
Oh, D.-Y., Ruth He, A., Qin, S., Chen, L.-T., Okusaka, T., Vogel, A., Kim, J. W., Suksombooncharoen, T., Ah Lee, M., Kitano, M., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200015 · Cited by 1,217
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Rabe, K. F., Martinez, F. J., Ferguson, G. T., Wang, C., Singh, D., Wedzicha, J. A., Trivedi, R., St. Rose, E., Ballal, S., McLaren, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916046 · Cited by 690
Ferguson, G. T., Rabe, K. F., Martinez, F. J., Fabbri, L. M., Wang, C., Ichinose, M., Bourne, E., Ballal, S., Darken, P., DeAngelis, K., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30327-8 · Cited by 379
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update
DeTora, L. M., Toroser, D., Sykes, A., Vanderlinden, C., Plunkett, F. J., Lane, T., Hanekamp, E., Dormer, L., DiBiasi, F., Bridges, D., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1460 · Cited by 258
Self-citation
Metadata
- Authors
- Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C. I., Citrome, L., Gurr, J. A., Mooney, L. A., Moore, B. J., Peña, T., Sanes-Miller, C. H., Veitch, K., Woolley, K. L., & Yarker, Y. E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-09-15
- Volume
- 163
- Issue
- 6
- Pages
- 461-464
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1890874870
- Cited by
- 358
- References
- 22
- FWCI
- 40.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. https://app.cochat.ai/papers/10.7326/m15-0288
- The paper
- Battisti, W. P., Wager, E., Baltzer, L., Bridges, D., Cairns, A., Carswell, C. I., Citrome, L., Gurr, J. A., Mooney, L. A., Moore, B. J., Peña, T., Sanes-Miller, C. H., Veitch, K., Woolley, K. L., & Yarker, Y. E. (2015). Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine. https://doi.org/10.7326/m15-0288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.